Environmentally and occupationally acquired diseases in adolescents and adulthood: Control of diphtheria, tetanus, pertussis, and poliomyelitis through regular booster vaccinations - A European perspective

Reviews on Environmental Health

Volumn 20, Issue 4, 2005, Pages 303-317

  Hofmann, Friedrich ^a  

^a UNIVERSITY OF WUPPERTAL   (Germany)

Author keywords

Infections; Vaccine; Whooping cough

Indexed keywords

DIPHTHERIA VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADOLESCENT DISEASE; ADULT; BORDETELLA PERTUSSIS; CHILDHOOD DISEASE; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; DIPHTHERIA; DISEASE TRANSMISSION; DOSE RESPONSE; DRUG DOSE REGIMEN; ENDEMIC DISEASE; ENVIRONMENTAL DISEASE; ERADICATION THERAPY; EUROPE; HEALTH SURVEY; HUMAN; IMMUNIZATION; IMMUNOPROPHYLAXIS; INFECTION CONTROL; INFECTION PREVENTION; INFECTION SENSITIVITY; OCCUPATIONAL DISEASE; PERTUSSIS; POLIOMYELITIS; POLIOMYELITIS VIRUS; REVIEW; TETANUS; TETANUS PROPHYLAXIS; VACCINATION;

BORDETELLA PERTUSSIS; CLOSTRIDIUM TETANI; CORYNEBACTERIUM DIPHTHERIAE; POLIOVIRUS;

EID: 29444458024     PISSN: 00487554     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVEH.2005.20.4.303     Document Type: Review

References (109)

1. Deen JL, Mink CA, Cherry JD, Christenson PD, Pineda EF, Lewis K et al. Household contact study of Bordetella pertussis infections. Clin Infect Dis 1995; 21: 1211-1219.
2. Grimprel E, Guiso N, Bégué P. New aspects of pertussis in France, 26 years after generalized pertussis vaccination. Biologicals 1993; 21: 5-6.
3. Baron S, Njamkepo E, Grimprel E, Begue P, Desenclos JC, Drucker J et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatr Infect Dis J 1998; 17: 412-418.
4. Kwantes W. Diphtheria in Europe. J Hyg (Lond) 1984; 93: 433-437.
5. Hasselhorn HM. [Prevention of diphtheria in Germany: yesterday, today, tomorrow - an overview]. Gesundheitswesen 2001; 63: 735-740.
6. World Health Organization. Expanded programme on immunization (EPI). Update: diphtheria epidemic in the newly independent states of the former USSR, January 1995-March 1996. Wkly Epidemiol Rec 1996; 71: 245-250.
7. Galazka AM, Robertson SE. Immunization against diphtheria with special emphasis on immunization of adults. Vaccine 1996; 14: 845-857.
8. Hardy IR, Dittmann S, Sutter RW. Current situation and control strategies for resurgence of diphtheria in newly independent states of the former Soviet Union. Lancet 1996; 347(9017): 1739-1744.
9. MacGregor RR. Corynebacterium diphtheriae. In: Mandell GL, Bennett JE, Dolin R, eds, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. New York, NY, USA: Churchill Livingstone, 2000; 2190-2198.
10. Böttiger M, Pettersson G. Vaccine immunity to diphtheria: a 20-year follow-up study. Scand J Infect Dis 1992; 24: 753-758.
11. Hasselhorn HM, Nübling M, Tiller FW, Hofmann F. Factors influencing immunity against diphtheria in adults. Vaccine 1998; 16: 70-75.
12. Matheï C, Van Damme P, Bruynseels P, Goossens H, Vranckx R, Meheus A. Diphtheria immunity in Flanders. Eur J Clin Microbiol Infect Dis 1997; 16: 631-636.
13. Ballereau F, Schrive I, Fisch A, Speich M, Laurichesse H, Tournade S, et al. A multicentre serosurvey on diphtheria immunity in a French population of 1004 subjects. Eur J Epidemiol 1998; 14: 499-503.
14. Souliou E, Kyriazopoulou V, Diza E, Hatzistylianou M, Frantzidou F. Serological survey on the immunity to diphtheria of the northern Greek population. Eur J Epidemiol 1997; 13: 535-539.
15. Bergamini M, Comodo N, Gasparini R, Gabutti G, Fabrizi P, Severini R, et al. Prevalence of diphtheria toxin antibodies in human sera from a cross-section of the Italian population. Vaccine 1999; 17: 286-290.
16. Garcia-Corbeira P, Dal-Ré R, Garcia-de-Lomas J, Aguilar L. Low prevalence of diphtheria immunity in the Spanish population: results of a cross-sectional study. Vaccine 1999; 17: 1978-1982.
17. Maple PAC, Jones CS, Wall EC, Vyse A, Edmunds WJ, Andrews NJ, et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2001; 19: 167-173.
18. Galazka AM, Robertson SE. Diphtheria: Changing patterns in the developing world and the industrialized world. Eur J Epidemiol 1995; 11: 107-117.
19. Zastrow KD, Schöneberg I. Tetanus-Erkrankungen, Impfungen und Impfschäden in der Bundesrepublik Deutschland 1971-1990. Dtsch Med Wochenschr 1993; 118: 1617-1620.
20. Antona D. Le tétanos en France en 2000 et 2001. BEH 2002; 40: 197-199.
21. Rushdy AA, White JM, Ramsay ME, Crowcroft NS. Tetanus in England and Wales, 1984-2000. Epidemiol Infect 2003; 130: 71-77.
22. Fisch A. Couverture vaccinale anti-tétanique (Tetanus immunization coverage). Med Mal Infect 1995; 25: 627-631.
23. Klouche M, Gorg S, Wilhelm D, Kirchner H. Sex-dependent and age-dependent gaps in the immunological protection against tetanus. Dtsch Med Wochenschr 1994; 119: 827-832.
24. Murphy SM, Hegarty DM, Feighery CS, Walsh JB, Williams Y, Coakley DP. Tetanus immunity in elderly people. Age Ageing 1995; 24: 99-102.
25. Reid PM, Brown D, Coni N, Sama A, Waters M. Tetanus immunization in the elderly population. J Accid Emerg Med 1996; 13: 184-185.
26. Vidal J. The prevalence of antitetanic antibodies in the adult population in Catalonia. Med Clin 1992; 99: 6-8.
27. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761-766.
28. World Health Organization. Progress towards global eradication of poliomyelitis, 2002 . Wkly Epidemiol Rec 2003; 78: 138-144.
29. World Health Organization. Global eradication of poliomyelitis by the year 2000. Wkly Epidemiol Rec 1988; 22: 161-162.
30. World Health Organization. Progress towards global poliomyelitis eradication. The approaching extinction of wild poliovirus type 2. Wkly Epidemiol Rec 1999; 74: 286-288.
31. Hull HF, Ward NA, Hull BP, Milstien JB. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994; 343: 1331-1337.
32. Bompart F. [Global poliomyelitis eradication and vaccination strategies]. Med Mal Infect 2003; 33: 119-124.
33. Oostvogel PM, van Wijngaarden JK, van der Avoort HG, Mulders MN, Conyn-van Spaendonck MA, Rumke HC, et al. Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93. Lancet 1994; 344: 665-670.
34. Furesz J, Armstrong RE, Contreras G. Viral and epidemiological links between poliomyelitis outbreaks in unprotected communities in Canada and the Netherlands. Lancet 1978; 2(8102): 1248.
35. Foote FM, Kraus G, Andrews MD, Hart JC. Polio outbreak in a private school. Conn Med 1993; 37: 643-644.
36. Schonberger LB, Kaplan J, Kim-Farley R, Moore M, Eddins DL, Hatch M. Control of paralytic poliomyelitis in the United States. Rev Infect Dis 1984; 6 Suppl 2: S424-S426.
37. World Health Organization. Poliomyelitis outbreak in Bulgaria. Wkly Epid Rec 1992; 45: 336-337.
38. World Health Organization. Mass vaccination campaigns to control the 1991-92 poliomyelitis outbreak in Jordania. Wkly Epid Rec 1993; 30: 222-223.
39. World Health Organization. Poliomyelitis outbreak in Albania. Wkly Epid Rec 1996; 29: 220-221.
40. Ellis CJ, Telfer P, Lawton NF. Poliomyelitis in the UK. Lancet 1990; 335(8685): 364.
41. Mastroeni I, Patti AM, Fabrizi A, Santi AL, Manduca AM, Vescia N, et al. Immunity status against poliomyelitis in persons 13-14 years old living in Rome. Vaccine 1997; 15: 747-750.
42. White PM, Green J. Prevalence of antibody to poliovirus in England and Wales 1984-6. Br Med J (Clin Res Ed) 1986; 293(6555): 1153-1155.
43. Squarcione S, Germinario C, Iandolo E, Lo CS, Bergamini F, Profeta ML, et al. Seroimmunity to poliomyelitis in an Albanian immigrant population. Vaccine 1992; 10: 853-856.
44. Borcic B, Kuzic V, Kaic B, Ljubicic M, Ljubin-Sternak S. Immunity of the Croatian population to poliomyelitis-a serosurvey. Acta Med Croat 1998; 52: 229-233.
45. Malvy D, Fuchs F, Dubois F, Roure C, Aymard M, Drucker J. A study of poliomyelitis related sero-immunity in a selected sample of the French population. Med Mal Infect 1996; 26: 714-720.
46. Bégué P, Baron S, Grimprel E. Epidemiology of pertussis in European region. Med Mal Infect 1995; 25: 1263-1267.
47. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988; 296: 612-614.
48. Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28: 1230-1237.
49. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis 2000; 182: 1409-1416.
50. Campins-Marti M, Cheng HK, Forsyth K, Guiso N, Halperin S, Huang LM et al. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2002; 20: 641-646.
51. Mink CM, Cherry JD, Christenson P. A search for Bordetella pertussis infection in University students. Clin Infect Dis 1992; 14: 464-471.
52. Schmitt-Grohé S, Cherry JD, Heininger U, Überall MA, Pineda E, Stehr K. Pertussis in German adults. Clin Infect Dis 1995; 21: 860-866.
53. Nennig ME, Shinefield HR, Edwards RM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275: 1672-1674.
54. Gilberg S, Njamkepo E, Parent du Châtelet I, Partouche H, Gueirard P, Ghasarossian C et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis 2002; 186: 415-418.
55. Wirsing von König CH, Riffelmann M. Pertussis: Wen sollen wir Impfen? In: Schmitt HJ, ed, Alte und Neue Impfstoffe in Deutschland. Grundlage für künftige Entscheidungen, Infomed Verlag Berlin 2002; 2: 37-49.
56. Güris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 1999; 28: 1230-1237.
57. Mink CA, Sirota NM, Nugent S. Outbreak of Pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med 1994; 148: 153-157.
58. Brennan M, Strebel P, George H, Yih WK, Tachdjian R, Lett SM, et al. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis 2000; 181: 210-215.
59. Cattaneo LA, Reed GW, Haase DH, Wills MJ, Edwards KM. The seroepidemiology of Bordetella pertussis infections: a study of persons ages 1-65 years. J Infect Dis 1996; 173: 1256-1259.
60. Deville JG, Cherry JD, Christenson PD, Pineda E, Leach CT, Kuhls TL, et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 1995; 21: 639-642.
61. Kurt TL, Yeager AS, Guenette S, Dunlop S. Spread of pertussis by hospital staff. JAMA 1972; 221: 264-267.
62. Gehanno JF, Pestel-Caron M, Marguet C, Nouvellon M, Gueit I. Pertussis outbreak in an outpatient hospital staff. Arch Pediatr 1998; 5: 92-93.
63. De Serres G, Shadmani R, Duval B, Boulianne N, Déry P, Douville-Fradet M, et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 2000; 182: 174-179.
64. Addiss DG, Davis JP, Meade BD. A pertussis outbreak in a Wisconsin nursing home. J Infect Dis 1991; 164: 704-710.
65. Editorial. Pertussis: adults, infants, and herds. Lancet 1992; 339(8792): 526-527.
66. Postels-Multani S, Schmitt HJ, Wirsing von Konig CH, Bock HL, Bogaerts H. Symptoms and complications of pertussis in adults. Infection 1995; 23: 139-142.
67. Lee LH, Pichichero ME. Costs of illness due to Bordetella pertussis in families. Arch Fam Med 2000; 9: 989-996.
68. Jenkinson D. Natural course of 500 consecutive cases of whooping cough: A general practice population study. Br Med J 1995; 310: 299-302.
69. Miller E, Fleming DM, Ashworth LAE, Mabbett DA, Vurdien JE, Elliott TSJ. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health 2000; 3: 132-134.
70. Heininger U, Stehr K, Schmidt-Schläpfer G, Penning R, Vock R, Kleemann W et al. Bordetella pertussis infections and sudden unexpected deaths in children. Eur J Pediatr 1996; 155: 551-553.
71. Lindgren C, Milerad J, Lagercrantz H. Sudden infant death and prevalence of whooping cough in the Swedish and Norwegian communities. Eur J Pediatr 1997; 156:405-409.
72. Jansen DL, Gray GC, Putnam SD, Lynn F, Meade BD. Evaluation of pertussis in US Marine Corps trainees. Clin Infect Dis 1997; 25: 1099-1107.
73. Ing A. Chronic cough. Respirology 1997; 2: 309-316.
74. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273: 1044-1046.
75. Robertson PW, Goldberg H, Jarvie BH, Smith DD, Whybin LR. Bordetella pertussis infection: a cause of persistent cough in adults. Med J Aust 1987; 146: 522-525.
76. Rosenthal S, Strebel P, Cassiday P, Sanden G, Brusuelas K, Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 1995; 171: 1650-1652.
77. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997; 16: S85-S89.
78. Aoyama T, Harashima M, Nishimura K, Saito Y. Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families. Acta Paediatr Jpn Overs Ed 1995; 37: 321-324.
79. Bonmarin I, Laurent E, Guiso N, Lévy-Bruhl D. Renacoq: surveillance de la coqueluche à l'hôpital en 2001. BEH 2003; 2003: 213-214.
80. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child 2003; 88: 802-806.
81. Grimprel E, Baron S, Lévy-Bruhl D, Garnier JM, N'Jamkepo E, Guiso N et al. Influence of vaccination coverage on pertussis transmission in France. Lancet 1999; 354: 1699-1700.
82. Izurieta HS, Kenyon TA, Strebel PM, Baughman AL, Shulman ST, Wharton M. Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis 1996; 22: 503-507.
83. Wirsing von König CH, Postels-Multani S, Bock HL, Schmitt HJ. Pertussis in adults: Frequency of transmission after household exposure. Lancet 1995; 346: 1326-1329.
84. Mertsola J, Ruuskanen O, Eerola E, Viljanen MK. Intrafamilial spread of pertussis. J Pediatr 1983; 103: 359-363.
85. Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A. Preliminary assessment of the economic value of pertussis booster vaccination of hospital staff. Value Health 2000; 3: 124.
86. Botteman MF, Pashos CL, Hauser RS, Laskin BL, Redaelli A. Preliminary assessment of the economic value of adults pertussis booster vaccination. Value Health 2000; 3: 122-123.
87. Edsall G. Immunization of adults against diphtheria and tetanus. Am J Public Health 1952; 42: 393-400.
88. Björkholm B, Granstrom M, Wahl M, Hedström CE, Hagberg L. Adverse reactions and immunogenicity in adults to regular and increased dosage of diphtheria vaccine. Eur J Clin Microbiol 1987; 6: 637-640.
89. Settergren B, Broholm KA, Norrby SR, Christenson B. Diphtheria revaccination of adults. Lancet 1987; 1(8532): 557-558.
90. Simonsen O, Kjeldsen K, Vendborg HA, Heron I. Revaccination of adults against diphtheria. I: Responses and reactions to different doses of diphtheria toxoid in 30-70-year-old persons with low serum antitoxin levels. Acta Pathol Microbiol Immunol Scand 1986; 94: 213-218.
91. Simonsen O, Klaerke M, Klaerke A. Revaccination of adults against diphtheria. II: Combined diptheria and tetanus revaccination with different doses of diphteria toxoid 20 yeras after primary vaccination. Acta Pathol Microbiol Immunol Scand 1986; 94: 219-225.
92. Advisory Committee on Immunization Practices (ACIP). Poliomyelitis prevention in the United States-Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000; 49(RR-5): 1-22.
93. World Health Organization. Progress towards the global eradication of poliomyelitis, 2001. Wkly Epidemiol Rec 2002; 77: 98-107.
94. World Health Organization. Paralytic poliomyelitis in Madagascar, 2002. Wkly Epidemiol Rec 2002; 77: 241-242.
95. Wood D. Post eradication polio immunization policy development, status of programme and scientific research. WHO Technical Consulting Group 4-4-2002; 15, 140-145.
96. Plotkin SA. Inactivated polio vaccine for the United States: A missed vaccination opportunity. Pediatr Infect Dis J 1995; 14: 835-839.
97. Murdin AD, Barreto L, Plotkin S. Inactivated poliovirus vaccine: past and present experience. Vaccine 1996; 14: 735-746.
98. Böttiger M, Herrström E. Isolation of polio-viruses from sewage and their characteristics: experience over two decades in Sweden. Scand J Infect Dis 1992; 24: 151-155.
99. Drucker J. Poliomyelitis in France: epidemiology and vaccination status. Pediatr Infect Dis J 1991; 10: 967-969.
100. Anonymous. La poliomyélite en France en 1996. BEH 1998; N° Spécial Février: 21-22.
101. Keitel WA, Edwards KM. Acellular pertussis vaccines in adults. Infect Dis Clin North Am 1999; 13: 83-94.
102. Halp erin SA, Smith B, Russell M, Hasselback P, Guasparini R, Skowronski D, et al. An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 2000; 18: 1312-1319.
103. Halperin SA, Smith B, Russell M, Scheifele D, Mills E, Hasselback P, et al. Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J 2000; 19: 276-283.
104. Vellinga A, Van Damme P, Joossens E, Goossens H. Response to diphtheria booster vaccination in healthy adults: vaccine trial. Br Med J 2000; 320(7229): 217.
105. Veliinga A, Van Damme P, Joosens E, Van der Wielen M, Goossens H. Second diphtheria booster in adults raises immunity to 92%. Br Med J 2001; 323(7324): 1308.
106. STIKO. [Empfehlungen der Ständigen Impfkomission (STIKO) am Robert Koch-Institut/Stand: Juli 2005]. Epidemiologisches Bulletin 2005; 30: 257-272.
107. Anonymous. Calendrier vaccinal 1998 - Avis du Conseil supérieur d'hygiène publique de France du 13 mars 1998. BEH 1998; 15: 61-62.
108. EC directive /54/EC. Chapter 111, article 4, section 31990, 2000.
109. World Health Organization. Regional Office for Europe. Health 21: the health for all policy framework for the WHO European Region. European Health for All Series No. 6, 1999; 6.